Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$rhhby Graphic](https://lunarcrush.com/gi/w:26/t:$rhhby.png) $rhhby

Roche's blood test receives FDA clearance, boosting positive sentiment, while the company faces potential cancer risk concerns.

### About $rhhby
Roche ($rhhby) is a pharmaceutical company.  

### Engagements: XXXXX [#](/topic/$rhhby/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$rhhby/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$rhhby/time-series/interactions.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XXXXXX  
**1 Week**: XXXXXX -XX%  
**1 Month**: XXXXXXX -XX%  
**6 Months**: XXXXXXXXX -XX%  
**1 Year**: XXXXXXXXX -XX%  
**1-Year High**: XXXXXXX on 2024-12-05  
**1-Year Low**: XXX on 2025-10-18  

| Social Network | X     |
| -------------- | -     |
| Engagements    | XXXXX |
  

  
  
### Mentions: XX [#](/topic/$rhhby/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$rhhby/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$rhhby/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: XXX  
**6 Months**: XXXXX +73%  
**1 Year**: XXXXX +101%  
**1-Year High**: XXX on 2025-08-03  
**1-Year Low**: XX on 2025-01-27  

| Social Network | X  |
| -------------- | -  |
| Mentions       | XX |
  

  
  
### Creators: XX [#](/topic/$rhhby/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$rhhby/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$rhhby/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning $rhhby in the last XX hours which is up XXXX% from XX in the previous XX hours
**Daily Average**: XX  
**6 Months**: XXX -XX%  
**1 Year**: XXX +38%  
**1-Year High**: XXX on 2024-12-03  
**1-Year Low**: XX on 2025-01-27  

The most influential creators that mention $rhhby in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@SamFazeli8](/creator/twitter/SamFazeli8)           | X    | XXXXX     | X     | XXX         |
| [@TaxiBiotech](/creator/twitter/TaxiBiotech)         | X    | XXX       | X     | XXX         |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)           | X    | XXXXXX    | X     | XXX         |
| [@Quantumup1](/creator/twitter/Quantumup1)           | X    | XXXXX     | X     | XXX         |
| [@bioinvestor24](/creator/twitter/bioinvestor24)     | X    | XXXXX     | X     | XXX         |
| [@Roche](/creator/twitter/Roche)                     | X    | XXXXXXX   | X     | XXX         |
| [@MarcJacksonLA](/creator/twitter/MarcJacksonLA)     | X    | XXXXX     | X     | XXX         |
| [@BowTiedBiotech](/creator/twitter/BowTiedBiotech)   | X    | XXXXXX    | X     | XX          |
| [@yusufhameed](/creator/twitter/yusufhameed)         | X    | XXXXX     | X     | XX          |
| [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) | XX   | XXXXX     | X     | XX          |

[View More](/list/creators/$rhhby/100)
  
  
### Sentiment: XX% [#](/topic/$rhhby/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$rhhby/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$rhhby/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XXX% no change  
**1 Month**: XXX% +25%  
**6 Months**: XXX% +26%  
**1 Year**: XXX% +4%  
**1-Year High**: XXX% on 2024-10-19  
**1-Year Low**: XX% on 2025-08-02  

**Most Supportive Themes**
- **Positive Developments and Investments:** (40%) Roche is making significant investments and announcements, including expanding its manufacturing hub and building new facilities.
- **Positive Sentiment and Engagement:** (30%) The sentiment around $rhhby is up, with increased mentions and engagements across social networks.
- **Alnylam Partnership and Zilebesiran:** (20%) The partnership with Alnylam and the advancement of Zilebesiran into a Phase X cardiovascular outcomes trial is viewed positively.
  
**Most Critical Themes**
- **Potential Cancer Risk with GLP-1RA:** (10%)  Some posts discuss a potential link between long-term GLP-1RA use and increased cancer risk, particularly for women.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXX    | XX% | XXXXX   | XX% | XX       | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXX    | XX% | XXXXX   | XX% | XX       | X% |
  


**Top assets mentioned**
In the posts about $rhhby in the last XX hours

[Novo-Nordisk (NVO)](/topic/$nvo)
[Pfizer, Inc. (PFE)](/topic/$pfe)
[Eli Lilly and Company (LLY)](/topic/eli-lilly)
[AstraZeneca PLC (AZN)](/topic/$azn)
[Merck & Co., Inc. (MRK)](/topic/$mrk)
[ROGin AI (ROG)](/topic/$rog)
[Amgen, Inc. (AMGN)](/topic/$amgn)
[Akropolis (AKRO)](/topic/$akro)
[Eli Lilly and Company (LLY)](/topic/$lly)
[Biogen Inc (BIIB)](/topic/biogen-inc)

**Top topics mentioned**
In the posts about $rhhby in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [$nvo](/topic/$nvo), [$pfe](/topic/$pfe), [eli lilly](/topic/eli-lilly), [$azn](/topic/$azn), [$mrk](/topic/$mrk), [$rog](/topic/$rog), [$amgn](/topic/$amgn), [$akro](/topic/$akro), [$lly](/topic/$lly), [biogen inc](/topic/biogen-inc), [coins base ecosystem](/topic/coins-base-ecosystem), [gsk plc](/topic/gsk-plc), [$vktx](/topic/$vktx), [$bmy](/topic/$bmy), [$psnl](/topic/$psnl), [$etnb](/topic/$etnb), [$crsp](/topic/$crsp), [$edit](/topic/$edit), [stocks technology](/topic/stocks-technology), [johnson johnson](/topic/johnson-johnson), [$xbi](/topic/$xbi), [$sgmo](/topic/$sgmo), [$nvs](/topic/$nvs), [$tgtx](/topic/$tgtx), [$abbv](/topic/$abbv), [sanofi](/topic/sanofi), [$beam](/topic/$beam), [$mdgl](/topic/$mdgl), [stocks](/topic/stocks), [investments](/topic/investments), [$gsk](/topic/$gsk), [$biib](/topic/$biib), [microsoft](/topic/microsoft), [$msft](/topic/$msft), [$31b](/topic/$31b), [$51b](/topic/$51b), [$jnj](/topic/$jnj), [$mtsr](/topic/$mtsr), [acquisition](/topic/acquisition), [$bbio](/topic/$bbio), [novartis](/topic/novartis), [$idya](/topic/$idya), [gilead sciences](/topic/gilead-sciences), [$imvt](/topic/$imvt), [$roiv](/topic/$roiv), [$argx](/topic/$argx), [$mrna](/topic/$mrna), [$legn](/topic/$legn), [discount](/topic/discount), [$insm](/topic/$insm), [investment](/topic/investment), [$zeal](/topic/$zeal), [$35b](/topic/$35b), [$btq](/topic/$btq), [$ibb](/topic/$ibb), [$57b](/topic/$57b), [accuracy](/topic/accuracy), [$gpcr](/topic/$gpcr), [$rdgl](/topic/$rdgl), [$jazz](/topic/$jazz), [$arqt](/topic/$arqt), [$gkos](/topic/$gkos), [white house](/topic/white-house), [$tecx](/topic/$tecx), [$15b](/topic/$15b), [$novartis](/topic/$novartis), [$prax](/topic/$prax), [$cccc](/topic/$cccc), [stocks consumer defensive](/topic/stocks-consumer-defensive), [$form](/topic/$form), [coins dao](/topic/coins-dao), [alt aptoslaunch token](/topic/alt-aptoslaunch-token), [$alt](/topic/$alt), [$alec](/topic/$alec), [$advm](/topic/$advm), [$ntla](/topic/$ntla), [$nwbo](/topic/$nwbo), [novo](/topic/novo), [iii](/topic/iii), [$zlab](/topic/$zlab), [$knsa](/topic/$knsa), [$rhhbys](/topic/$rhhbys), [$sny](/topic/$sny), [boston](/topic/boston), [$qure](/topic/$qure), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [$regn](/topic/$regn), [why is](/topic/why-is), [$agio](/topic/$agio), [$11b](/topic/$11b), [$rani](/topic/$rani), [$lh](/topic/$lh), [$aeo](/topic/$aeo), [hp inc](/topic/hp-inc), [$hpq](/topic/$hpq), [approved](/topic/approved), [$zealco](/topic/$zealco), [youtube](/topic/youtube), [$bud](/topic/$bud)

### Top Social Posts [#](/topic/$rhhby/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Roche's Chugai inks $1.1B pact with Rani to move biologics beyond injections $RANI $RHHBY"  
[X Link](https://x.com/fwpharma/status/1979256390091751705) [@fwpharma](/creator/x/fwpharma) 2025-10-17T18:41Z 55.3K followers, XXX engagements


"Biotech daily update Oct 17: All Stock tickers: $NVO $LLY $KNSA $RANI $ACHV $XRTXF $ALPMY $TSHA $PRAX $IMAB $ATAI $EVAX $SNSE $NVS $TNXP $ABSCF $ELDN $PRTK $RHHBY $REGN $SNY $PLX $CHIESI"  
[X Link](https://x.com/TaxiBiotech/status/1979236391180554692) [@TaxiBiotech](/creator/x/TaxiBiotech) 2025-10-17T17:21Z XXX followers, XXX engagements


"$RHHBY CHMP backs EU approval of Roches Gazyva/Gazyvaro for lupus nephritis after phase III REGENCY shows XXXX% full renal response vs XXXX% with standard therapy. #newsrelease"  
[X Link](https://x.com/AponiaAnalytics/status/1979226503704379717) [@AponiaAnalytics](/creator/x/AponiaAnalytics) 2025-10-17T16:42Z 5209 followers, XX engagements


"$RHHBY - Roche's Elecsys pTau181 Becomes Only FDA-Cleared Blood Test For Use In Primary Care To Rule Out Alzheimer's-Related Amyloid Pathology #stocks"  
[X Link](https://x.com/QualityStocks/status/1979219636798337462) [@QualityStocks](/creator/x/QualityStocks) 2025-10-17T16:15Z 84.4K followers, XX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$rhhby Graphic $rhhby

Roche's blood test receives FDA clearance, boosting positive sentiment, while the company faces potential cancer risk concerns.

About $rhhby

Roche ($rhhby) is a pharmaceutical company.

Engagements: XXXXX #


Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXX -XX%
6 Months: XXXXXXXXX -XX%
1 Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2024-12-05
1-Year Low: XXX on 2025-10-18

Social Network X
Engagements XXXXX

Mentions: XX #


Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
6 Months: XXXXX +73%
1 Year: XXXXX +101%
1-Year High: XXX on 2025-08-03
1-Year Low: XX on 2025-01-27

Social Network X
Mentions XX

Creators: XX #


Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $rhhby in the last XX hours which is up XXXX% from XX in the previous XX hours Daily Average: XX
6 Months: XXX -XX%
1 Year: XXX +38%
1-Year High: XXX on 2024-12-03
1-Year Low: XX on 2025-01-27

The most influential creators that mention $rhhby in the last XX hours

Creator Rank Followers Posts Engagements
@SamFazeli8 X XXXXX X XXX
@TaxiBiotech X XXX X XXX
@BiopharmIQ X XXXXXX X XXX
@Quantumup1 X XXXXX X XXX
@bioinvestor24 X XXXXX X XXX
@Roche X XXXXXXX X XXX
@MarcJacksonLA X XXXXX X XXX
@BowTiedBiotech X XXXXXX X XX
@yusufhameed X XXXXX X XX
@AponiaAnalytics XX XXXXX X XX

View More

Sentiment: XX% #


Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XXX% +25%
6 Months: XXX% +26%
1 Year: XXX% +4%
1-Year High: XXX% on 2024-10-19
1-Year Low: XX% on 2025-08-02

Most Supportive Themes

  • Positive Developments and Investments: (40%) Roche is making significant investments and announcements, including expanding its manufacturing hub and building new facilities.
  • Positive Sentiment and Engagement: (30%) The sentiment around $rhhby is up, with increased mentions and engagements across social networks.
  • Alnylam Partnership and Zilebesiran: (20%) The partnership with Alnylam and the advancement of Zilebesiran into a Phase X cardiovascular outcomes trial is viewed positively.

Most Critical Themes

  • Potential Cancer Risk with GLP-1RA: (10%) Some posts discuss a potential link between long-term GLP-1RA use and increased cancer risk, particularly for women.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXXXX XX% XXXXX XX% XX X%
Total XXXXX XX% XXXXX XX% XX X%

Top assets mentioned In the posts about $rhhby in the last XX hours

Novo-Nordisk (NVO) Pfizer, Inc. (PFE) Eli Lilly and Company (LLY) AstraZeneca PLC (AZN) Merck & Co., Inc. (MRK) ROGin AI (ROG) Amgen, Inc. (AMGN) Akropolis (AKRO) Eli Lilly and Company (LLY) Biogen Inc (BIIB)

Top topics mentioned In the posts about $rhhby in the last XX hours

stocks healthcare, $nvo, $pfe, eli lilly, $azn, $mrk, $rog, $amgn, $akro, $lly, biogen inc, coins base ecosystem, gsk plc, $vktx, $bmy, $psnl, $etnb, $crsp, $edit, stocks technology, johnson johnson, $xbi, $sgmo, $nvs, $tgtx, $abbv, sanofi, $beam, $mdgl, stocks, investments, $gsk, $biib, microsoft, $msft, $31b, $51b, $jnj, $mtsr, acquisition, $bbio, novartis, $idya, gilead sciences, $imvt, $roiv, $argx, $mrna, $legn, discount, $insm, investment, $zeal, $35b, $btq, $ibb, $57b, accuracy, $gpcr, $rdgl, $jazz, $arqt, $gkos, white house, $tecx, $15b, $novartis, $prax, $cccc, stocks consumer defensive, $form, coins dao, alt aptoslaunch token, $alt, $alec, $advm, $ntla, $nwbo, novo, iii, $zlab, $knsa, $rhhbys, $sny, boston, $qure, regeneron pharmaceuticals inc, $regn, why is, $agio, $11b, $rani, $lh, $aeo, hp inc, $hpq, approved, $zealco, youtube, $bud

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Roche's Chugai inks $1.1B pact with Rani to move biologics beyond injections $RANI $RHHBY"
X Link @fwpharma 2025-10-17T18:41Z 55.3K followers, XXX engagements

"Biotech daily update Oct 17: All Stock tickers: $NVO $LLY $KNSA $RANI $ACHV $XRTXF $ALPMY $TSHA $PRAX $IMAB $ATAI $EVAX $SNSE $NVS $TNXP $ABSCF $ELDN $PRTK $RHHBY $REGN $SNY $PLX $CHIESI"
X Link @TaxiBiotech 2025-10-17T17:21Z XXX followers, XXX engagements

"$RHHBY CHMP backs EU approval of Roches Gazyva/Gazyvaro for lupus nephritis after phase III REGENCY shows XXXX% full renal response vs XXXX% with standard therapy. #newsrelease"
X Link @AponiaAnalytics 2025-10-17T16:42Z 5209 followers, XX engagements

"$RHHBY - Roche's Elecsys pTau181 Becomes Only FDA-Cleared Blood Test For Use In Primary Care To Rule Out Alzheimer's-Related Amyloid Pathology #stocks"
X Link @QualityStocks 2025-10-17T16:15Z 84.4K followers, XX engagements

$rhhby
/topic/$rhhby